Uterine Cancer Therapeutics & Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The uterine cancer therapeutics & diagnostics market is segmented by Type of Cancer (Endometrial Adenocarcinoma, Adenosquamous Carcinoma, Papillary Serous Carcinoma, Uterine Sarcoma), Product, and Geography

Uterine Cancer Therapeutics & Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Uterine Cancer Therapeutics & Diagnostics Market Size

Uterine Cancer Therapeutics & Diagnostics Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 6.00 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Uterine Cancer Therapeutics & Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Uterine Cancer Therapeutics & Diagnostics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Uterine Cancer Therapeutics & Diagnostics Market Analysis

The Uterine Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 6% during the forecast period.

Furthermore, developing countries like India has a National Cancer Control Programme which was established in 1975-76. This has contributed to the development of Regional Cancer Centres (RCCs), oncology wings in medical colleges and support for the purchase of teletherapy machines. In this country, the awareness programmes about the cancer are being conducted which is making the women aware of the severity of the disease.

Looking at the severity of the disease and importance of the women health, healthcare providers along with the governments are provoking awareness programmes in certain regions such as North America, Europe, and Asia-Pacific. With the growing focus of the government and the healthcare providers, it has been indicated that the market will grow rapidly in the over the forecast period.

Uterine Cancer Therapeutics & Diagnostics Industry Overview

The market studied is moderately competitive and most of the companies dealing with this market are the global players. However, with the rising technological advancements, smaller companies are also focusing on market penetration and are taking efforts to grab enough market share.

Uterine Cancer Therapeutics & Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Becton Dickinson and Company

  3. Merck & Co., Inc.

  4. Takeda Pharmaceutical Company Limited

  5. GlaxoSmithKline Plc.

  6. *Disclaimer: Major Players sorted in no particular order
Uterine Cancer Therapeutics & Diagnostics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Uterine Cancer Therapeutics & Diagnostics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Awareness About Uterine Diseases and Their Available Therapies
    • 4.2.2 Increasing Health Care Expenditure
    • 4.2.3 Innovation in Drug Development and Subsequent Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Low Success Rate in Clinical Trials for Cancer Drugs
    • 4.3.2 High Cost Associated With the Treatment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Cancer Type
    • 5.1.1 Endometrial Adenocarcinoma
    • 5.1.2 Adenosquamous Carcinoma
    • 5.1.3 Papillary Serous Carcinoma
    • 5.1.4 Uterine Sarcoma
  • 5.2 By Product
    • 5.2.1 Therapeutics
    • 5.2.1.1 Surgery
    • 5.2.1.2 Immunotherapy
    • 5.2.1.3 Radiation Therapy
    • 5.2.1.4 Chemotherapy
    • 5.2.1.5 Others
    • 5.2.2 Diagnostics
    • 5.2.2.1 Biopsy
    • 5.2.2.2 Pelvic Ultrasound
    • 5.2.2.3 Hysteroscopy
    • 5.2.2.4 Dilation and Curettage
    • 5.2.2.5 CT Scan
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ariad Pharmaceuticals, Inc.
    • 6.1.2 Abbott Laboratories
    • 6.1.3 Becton, Dickinson & Co.
    • 6.1.4 GlaxoSmithKline Plc
    • 6.1.5 Merck & Co., Inc.
    • 6.1.6 Novartis AG
    • 6.1.7 Sanofi
    • 6.1.8 Siemens Healthcare Inc.
    • 6.1.9 Roche Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Uterine Cancer Therapeutics & Diagnostics Industry Segmentation

As per the scope of the report, uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. The market is segmented by type of cancer, therapeutics, diagnostics and geography.

By Cancer Type Endometrial Adenocarcinoma
Adenosquamous Carcinoma
Papillary Serous Carcinoma
Uterine Sarcoma
By Product Therapeutics Surgery
Immunotherapy
Radiation Therapy
Chemotherapy
Others
Diagnostics Biopsy
Pelvic Ultrasound
Hysteroscopy
Dilation and Curettage
CT Scan
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Uterine Cancer Therapeutics & Diagnostics Market Research FAQs

What is the current Uterine Cancer Therapeutics & Diagnostics Market size?

The Uterine Cancer Therapeutics & Diagnostics Market is projected to register a CAGR of 6% during the forecast period (2025-2030)

Who are the key players in Uterine Cancer Therapeutics & Diagnostics Market?

Abbott Laboratories, Becton Dickinson and Company, Merck & Co., Inc., Takeda Pharmaceutical Company Limited and GlaxoSmithKline Plc. are the major companies operating in the Uterine Cancer Therapeutics & Diagnostics Market.

Which is the fastest growing region in Uterine Cancer Therapeutics & Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Uterine Cancer Therapeutics & Diagnostics Market?

In 2025, the North America accounts for the largest market share in Uterine Cancer Therapeutics & Diagnostics Market.

What years does this Uterine Cancer Therapeutics & Diagnostics Market cover?

The report covers the Uterine Cancer Therapeutics & Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Uterine Cancer Therapeutics & Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Uterine Cancer Therapeutics & Diagnostics Industry Report

Statistics for the 2025 Uterine Cancer Therapeutics & Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Uterine Cancer Therapeutics & Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.